Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145

JOURNAL ARTICLE published 1 May 2017 in Molecular Cancer Therapeutics

Research funded by NIH/NCI (CA165980,CA177665,CA112557) | NIH/NIEHS (ES000260) | Key Project of Science and Technology Innovation Team of Zhejiang Province (2013TD10)

Authors: Guosong Jiang | Chao Huang | Jingxia Li | Haishan Huang | Honglei Jin | Junlan Zhu | Xue-Ru Wu | Chuanshu Huang